Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England

January 23, 2016 at 10:36 am

EID FEB 2016 V.22 N.2

Dispatch

Shamez N. Ladhani, Marzia Monica Giuliani, Alessia Biolchi, Mariagrazia Pizza, Kazim Beebeejaun, Jay Lucidarme, Jamie Findlow, Mary E. Ramsay, and Ray Borrow

St. George’s University of London Paediatric Infectious Diseases Research Group, London, UK (S.N. Ladhani); Public Health England, London (S.N. Ladhani, K. Beebeejaun, M.E. Ramsay); GSK Vaccines, Siena, Italy (M.M. Giuliani, A. Biolchi, M. Pizza); Public Health England, Manchester, UK (J. Lucidarme, J. Findlow, R. Borrow)

Serum samples from children immunized with a meningococcal serogroup B vaccine demonstrated potent serum bactericidal antibody activity against the hypervirulent Neisseria meningitidis serogroup W strain circulating in England.

The recent introduction of this vaccine into the United Kingdom national immunization program should also help protect infants against this endemic strain.

PDF

http://wwwnc.cdc.gov/eid/article/22/2/pdfs/15-0369.pdf

Entry filed under: Bacterias, Bacteriemias, Epidemiología, FIEBRE y RASH, Inmunizaciones, Metodos diagnosticos, Sepsis, Update. Tags: .

Zika Virus Spreads to New Areas — Region of the Americas, May 2015–January 2016 Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection — United States, 2016


Calendar

January 2016
M T W T F S S
« Dec   Feb »
 123
45678910
11121314151617
18192021222324
25262728293031

Most Recent Posts


%d bloggers like this: